| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-11 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-09 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-08 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-08 |